PDSB - Wall Street Estimates - PDS Biotechnology Corporation

Healthcare - Biotechnology - NASDAQ - US

$ 1.33

-2.21 %

$ 49.8 M

Market Cap

-1.14

P/E

Price Target Average

651.88%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

--2.86%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets PDS Biotechnology Corporation

Wall Street analysts predict an average 1-year price target for PDSB of $10 , with forecasts ranging from a low of $9 to a high of $11 .

PDSB Lowest Price Target Wall Street Target

9 USD 576.69%

PDSB Average Price Target Wall Street Target

10 USD 651.88%

PDSB Highest Price Target Wall Street Target

11 USD 727.07%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free